Breaking News Instant updates and real-time market news.

MTH

Meritage Homes

$52.15

0.45 (0.87%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08

Meritage Homes upgraded to Outperform at Credit Suisse

As previously reported, Credit Suisse analyst Susan Maklari upgraded Meritage Homes to Outperform from Neutral as she looks for peer relative outperformance in the upcoming year. The analyst also raised her price target on the shares to $60 from $52.

  • 01

    Feb

MTH Meritage Homes
$52.15

0.45 (0.87%)

01/22/18
FBCO
01/22/18
UPGRADE
FBCO
Outperform
Meritage Homes upgraded to Outperform from Neutral at Credit Suisse
01/08/18
SBSH
01/08/18
UPGRADE
Target $64
SBSH
Buy
Meritage Homes upgraded to Buy from Neutral at Citi
Citi analyst Will Randow upgraded Meritage Homes to Buy and raised his price target for the shares to $64 from $53. States like Texas and Florida, along with other Meritage markets, will be the biggest benefactors of personal tax reform, Randow tells investors in a research note. He sees the company as one of the better benefactors from possible acquisition in the sector and notes the shares screen cheap.
10/25/17
UBSW
10/25/17
INITIATION
Target $52
UBSW
Neutral
Meritage Homes initiated with a Neutral at UBS
UBS analyst Daniel Oppenheim started Meritage Homes with a Neutral rating and $52 price target.
07/11/17
LEHM
07/11/17
DOWNGRADE
Target $37
LEHM
Toll Brothers downgraded to Underweight from Equal Weight at Barclays
As previously reported, Barclays analyst Michael Dahl downgraded Toll Brothers (TOL) to Underweight and keeps a $37 price target for the shares. The analyst says his firm's June agency survey indicated moderating buyer traffic trends. He sees risk that near-term catalysts for builders will disappoint relative to rising expectations. As such, Dahl recommends "tactically" reducing exposure to homebuilder stocks. Along with Toll Brothers, the analyst this morning downgraded TRI Pointe (TPH), PulteGroup (PHM) and Lennar (LEN) to Equal Weight. He also upgraded CalAtlantic (CAA) to Equal Weight. Dahl reiterates Underweight ratings on KB Home (KBH), Meritage Homes (MTH) and Realogy (RLGY).

TODAY'S FREE FLY STORIES

DCPH

Deciphera

$44.61

2.73 (6.52%)

08:16
06/19/18
06/19
08:16
06/19/18
08:16
Recommendations
Deciphera analyst commentary  »

Deciphera price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CNI

Canadian National

$82.47

-0.69 (-0.83%)

08:15
06/19/18
06/19
08:15
06/19/18
08:15
Hot Stocks
CN to invest $210M to expand, strengthen Saskatchewan rail network »

CN said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$354.79

-2.78 (-0.78%)

08:15
06/19/18
06/19
08:15
06/19/18
08:15
Technical Analysis
Technical Take: Boeing falls in pre-market, breaks uptrend support line »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$3.20

0.18 (5.96%)

, REV

Revlon

$18.65

-0.2 (-1.06%)

08:15
06/19/18
06/19
08:15
06/19/18
08:15
Hot Stocks
Blue Apron appoints Alan Blake Chief Supply Chain Officer »

Blue Apron (APRN)…

APRN

Blue Apron

$3.20

0.18 (5.96%)

REV

Revlon

$18.65

-0.2 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

08:15
06/19/18
06/19
08:15
06/19/18
08:15
General news
Housing Starts Permits to be reported at 08:30 »

May Housing Starts…

08:15
06/19/18
06/19
08:15
06/19/18
08:15
General news
Housing Starts to be reported at 08:30 »

May Housing Starts will…

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

08:13
06/19/18
06/19
08:13
06/19/18
08:13
Periodicals
Jailed Audi CEO pledges to cooperate with emissions-cheating probe, WSJ reports »

CEO of Volkswagen's…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$18.74

0.02 (0.11%)

, FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:13
06/19/18
06/19
08:13
06/19/18
08:13
Conference/Events
People's United to host conference call »

Conference call to…

PBCT

People's United

$18.74

0.02 (0.11%)

FBNK

First Connecticut

$26.05

0.15 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NTRA

Natera

$14.38

0.12 (0.84%)

08:09
06/19/18
06/19
08:09
06/19/18
08:09
Hot Stocks
Natera announces research collaboration with Institut Jules Bordet »

Natera announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

BKYI

BIO-key

$2.42

0.02 (0.83%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
BIO-key awarded U.S. patent for Utilization of Biometric Data »

BIO-key International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRON

Cronos Group

$6.77

-0.25 (-3.56%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
Cronos Group granted medicinal cannabis Manufacture License in Australia »

Cronos Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CVS

CVS Health

$67.73

-2.37 (-3.38%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
CVS Pharmacy: Prescription delivery now available nationwide »

CVS Pharmacy, the retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNA

Allena Pharmaceuticals

$13.48

-0.08 (-0.59%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
Allena Pharmaceuticals completes animal proof-of-concept study for ALLN-346 »

Allena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$17.78

0.1 (0.57%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Downgrade
Mattel rating change  »

Mattel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$14.68

2.655 (22.08%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Downgrade
Rent-A-Center rating change  »

Rent-A-Center downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.67

-0.03 (-1.11%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Hot Stocks
Citius Pharmaceuticals announces Mino-Lok is now a registered trademark »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$6.19

-0.91 (-12.82%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Hot Stocks
IRIDEX announces approval of CYCLO G6 Glaucoma Laser system in Korea »

IRIDEX announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, DIA

Diamonds Fund ETF

$249.72

-0.99 (-0.39%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Technical Analysis
Technical Take: Diamonds Fund ETF breaks uptrend support line in pre-market »

As trade war and other…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

DIA

Diamonds Fund ETF

$249.72

-0.99 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RSLS

ReShape Lifesciences

$3.07

-0.05 (-1.60%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
ReShape Lifesciences receives issue notification for ReShape Vest patent »

ReShape Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.55

-0.0816 (-12.92%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Syndicate
Matinas BioPharma raises $8M in a public offering »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISR

IsoRay

$0.45

0.0095 (2.16%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
IsoRay enters one-year employment contract with Lori Woods as Interim CEO »

IsoRay announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSKN

Strata Skin Sciences

$2.11

0.09 (4.46%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Strata announces 510(k) submission for Multi-Micro Dose tip accessory »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$202.60

1.06 (0.53%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Raytheon awarded $161M contract from U.S. Army »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LASR

nLight

$38.51

-0.05 (-0.13%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
nLight analyst commentary  »

nLight price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$21.70

-0.1 (-0.46%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.